FDA Drug Recalls

Recalls / Class II

Class IID-0298-2026

Product

INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01

Brand name
Inon Ace
Generic name
Magnesium Aluminosilicates, Magnesium Hydroxide, Simethicone
Active ingredients
Dimethicone, Magnesium Hydroxide, Silodrate
Route
Oral
NDC
49873-402
FDA application
M001
Affected lot / code info
Lot#: PWXT, Exp 1/31/2027

Why it was recalled

Failed Disintegration Specifications: above the time expected.

Recalling firm

Firm
Sato Pharmaceutical Co., Ltd
Manufacturer
Sato Pharmaceutical Co., Ltd.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
Ahc Building 1-5-27, N/A, Tokyo, N/A N/A, Japan

Distribution

Quantity
3,640 bottles
Distribution pattern
CA and HI

Timeline

Recall initiated
2025-12-19
FDA classified
2026-01-27
Posted by FDA
2026-02-04
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0298-2026. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Inon Ace · FDA Drug Recalls